Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats

Physiology and Behavior

Volumn 107, Issue 5, 2012, Pages 726-732

  Lungwitz, Elizabeth A ^a,b   Molosh, Andrei ^b,c   Johnson, Philip L ^b,c   Harvey, Brian P ^d   Dirks, Rachel C ^e   Dietrich, Amy ^e   Minick, Pamela ^e   Shekhar, Anantha ^b,c   Truitt, William A ^b,c,e  

^a Graduate Program in Medical Neuroscience   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Institute of Psychiatric Research   (United States)

^d Project SEED and Cathedral High School   (United States)

^e Department of Anatomy and Cellular Biology ^*  (United States)

Author keywords

Anxiety; Bed nucleus of the stria terminalis; Neuropeptide

Indexed keywords

GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OREXIN A;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; MALE; MAZE TEST; MEMBRANE DEPOLARIZATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; SOCIAL INTERACTION; STRIA TERMINALIS;

ANIMALS; ANXIETY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAZE LEARNING; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; SEPTAL NUCLEI; SOCIAL BEHAVIOR;

EID: 84870694726     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.05.019     Document Type: Article

References (65)

1. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95:322-327.
2. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
3. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
4. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999, 827:243-260.
5. Sakurai T. Orexin: a link between energy homeostasis and adaptive behaviour. Curr Opin Clin Nutr Metab Care 2003, 6:353-360.
6. Thompson J.L., Borgland S.L. A role for hypocretin/orexin in motivation. Behav Brain Res 2011, 217:446-453.
7. Sakurai T., Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol Sci 2011, 32:451-462.
8. Kuwaki T. Orexin links emotional stress to autonomic functions. Auton Neurosci 2011, 161:20-27.
9. Boutrel B., Cannella N., de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 2010, 1314:103-111.
10. Brundin L., Bjorkqvist M., Petersen A., Traskman-Bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol 2007, 17:573-579.
11. Brundin L., Petersen A., Bjorkqvist M., Traskman-Bendz L. Orexin and psychiatric symptoms in suicide attempters. J Affect Disord 2007, 100:259-263.
12. Rotter A., Asemann R., Decker A., Kornhuber J., Biermann T. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder. J Affect Disord 2011, 131:186-192.
13. Schmidt F.M., Brugel M., Kratzsch J., Strauss M., Sander C., Baum P., et al. Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neurosci Lett 2010, 483:20-22.
14. Strawn J.R., Pyne-Geithman G.J., Ekhator N.N., Horn P.S., Uhde T.W., Shutter L.A., et al. Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder. Psychoneuroendocrinology 2010, 35:1001-1007.
15. Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., et al. A key role for orexin in panic anxiety. Nat Med 2010, 16:111-115.
16. Perna G., Guerriero G., Caldirola D. Emerging drugs for panic disorder. Expert Opin Emerg Drugs 2011, 16:631-645.
17. Borgland S.L., Labouebe G. Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential. Neuropsychopharmacology 2010, 35:353-354.
18. Avolio E., Alo R., Carelli A., Canonaco M. Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster. Behav Brain Res 2011, 218:288-295.
19. Suzuki M., Beuckmann C.T., Shikata K., Ogura H., Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 2005, 1044:116-121.
20. Plaza-Zabala A., Martin-Garcia E., de Lecea L., Maldonado R., Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 2010, 30:2300-2310.
21. Li Y., Li S., Wei C., Wang H., Sui N., Kirouac G.J. Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology 2010, 212:251-265.
22. Singareddy R., Uhde T., Commissaris R. Differential effects of hypocretins on noise-alone versus potentiated startle responses. Physiol Behav 2006, 89:650-655.
23. Panhelainen A.E., Korpi E.R. Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study. Pharmacol Biochem Behav 2011, 101:115-124.
24. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 2000, 270:318-323.
25. Johnson P.L., Samuels B.C., Fitz S.D., Federici L., Hammes N., Early M.C., et al. Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol Behav 2012, 107:732-741. (this issue).
26. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007, 8:171-181.
27. Trivedi P., Yu H., MacNeil D.J., Van der Ploeg L.H., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 1998, 438:71-75.
28. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001, 435:6-25.
29. Lee Y., Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 1997, 17:6434-6446.
30. Treit D., Aujla H., Menard J. Does the bed nucleus of the stria terminalis mediate fear behaviors?. Behav Neurosci 1998, 112:379-386.
31. Sullivan G.M., Apergis J., Bush D.E., Johnson L.R., Hou M., Ledoux J.E. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 2004, 128:7-14.
32. Davis M. Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 2006, 61:741-756.
33. Sink K.S., Walker D.L., Yang Y., Davis M. Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures. J Neurosci 2011, 31:1802-1810.
34. Waddell J., Morris R.W., Bouton M.E. Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci 2006, 120:324-336.
35. Walker D.L., Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 1997, 17:9375-9383.
36. Lee Y., Fitz S., Johnson P.L., Shekhar A. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety. Neuropsychopharmacology 2008, 33:2586-2594.
37. Sajdyk T., Johnson P., Fitz S., Shekhar A. Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior. J Psychopharmacol 2008, 22:633-641.
38. Eriksson K.S., Sergeeva O., Brown R.E., Haas H.L. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001, 21:9273-9279.
39. Follwell M.J., Ferguson A.V. Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. J Physiol 2002, 545:855-867.
40. Burdakov D., Liss B., Ashcroft F.M. Orexin excites GABAergic neurons of the arcuate nucleus by activating the sodium--calcium exchanger. J Neurosci 2003, 23:4951-4957.
41. Yang B., Samson W.K., Ferguson A.V. Excitatory effects of orexin-A on nucleus tractus solitarius neurons are mediated by phospholipase C and protein kinase C. J Neurosci 2003, 23:6215-6222.
42. Wu M., Zaborszky L., Hajszan T., van den Pol A.N., Alreja M. Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J Neurosci 2004, 24:3527-3536.
43. + channels in isolated locus coeruleus neurons. Neurosci Res 2005, 51:55-65.
44. Brown R.E., Winston S., Basheer R., Thakkar M.M., McCarley R.W. Electrophysiological characterization of neurons in the dorsolateral pontine rapid-eye-movement sleep induction zone of the rat: intrinsic membrane properties and responses to carbachol and orexins. Neuroscience 2006, 143:739-755.
45. Govindaiah G., Cox C.L. Modulation of thalamic neuron excitability by orexins. Neuropharmacology 2006, 51:414-425.
46. Kolaj M., Doroshenko P., Yan Cao X., Coderre E., Renaud L.P. Orexin-induced modulation of state-dependent intrinsic properties in thalamic paraventricular nucleus neurons attenuates action potential patterning and frequency. Neuroscience 2007, 147:1066-1075.
47. 2+ transients mediated by L-type calcium channels. J Neurophysiol 2008, 100:2265-2281.
48. Kolaj M., Coderre E., Renaud L.P. Orexin peptides enhance median preoptic nucleus neuronal excitability via postsynaptic membrane depolarization and enhancement of glutamatergic afferents. Neuroscience 2008, 155:1212-1220.
49. Kim J., Nakajima K., Oomura Y., Wayner M.J., Sasaki K. Electrophysiological effects of orexins/hypocretins on pedunculopontine tegmental neurons in rats: an in vitro study. Peptides 2009, 30:191-209.
50. Henny P., Brischoux F., Mainville L., Stroh T., Jones B.E. Immunohistochemical evidence for synaptic release of glutamate from orexin terminals in the locus coeruleus. Neuroscience 2010, 169:1150-1157.
51. Moorman D.E., Aston-Jones G. Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences. J Neurosci 2010, 30:15585-15599.
52. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
53. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier Academic Press, Amsterdam; Boston. 5th ed.
54. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 1999, 100:207-215.
55. Johnson P.L., Shekhar A. Panic-prone state induced in rats with GABA dysfunction in the dorsomedial hypothalamus is mediated by NMDA receptors. J Neurosci 2006, 26:7093-7104.
56. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 1980, 2:219-238.
57. Shekhar A., Keim S.R. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J Neurosci 1997, 17:9726-9735.
58. Molosh A.I., Johnson P.L., Fitz S.D., Dimicco J.A., Herman J.P., Shekhar A. Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorder. Neuropsychopharmacology 2010, 35:1333-1347.
59. Nollet M., Gaillard P., Minier F., Tanti A., Belzung C., Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 2011, 61:336-346.
60. Louhivuori L.M., Jansson L., Nordstrom T., Bart G., Nasman J., Akerman K.E. Selective interference with TRPC3/6 channels disrupts OX1 receptor signalling via NCX and reveals a distinct calcium influx pathway. Cell Calcium 2010, 48:114-123.
61. 2+ influx pathway necessary for coupling to phospholipase C. J Biol Chem 2000, 275:30806-30812.
62. Van Den Pol A.N., Patrylo P.R., Ghosh P.K., Gao X.B. Lateral hypothalamus: early developmental expression and response to hypocretin (orexin). J Comp Neurol 2001, 433:349-363.
63. van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998, 18:7962-7971.
64. 2+ signaling in dopamine neurons of the ventral tegmental area. Neuroreport 2001, 12:1885-1889.
65. Bartfai T., Iverfeldt K., Fisone G., Serfozo P. Regulation of the release of coexisting neurotransmitters. Annu Rev Pharmacol Toxicol 1988, 28:285-310.